Abstract: A portable health device comprises a housing at least one power source connected to the housing, a frequency oscillation device in communication with the power source, and at least one electromagnet carried by the housing and in communication with the at least one power source. The frequency oscillation device may be adapted to convert power from the power source to a pulse having a predetermined frequency. The pulse may charge the at least one electromagnet to emit a pulsed electromagnetic wave onto a user.

Abstract: The present invention relates to certain benzoamide piperidine containing compounds and related compounds that exhibit activity as NK-1 receptor antagonists, (e.g., substance P receptor antagonists), to pharmaceutical compositions containing them, and to their use in the treatment and prevention of central nervous system disorders, inflammatory disorders, cardiovascular disorders, ophthalmic disorders, gastrointestinal disorders, disorders caused by helicobacter pylori, disorders of the immune system, urinary incontinence, pain, migraine, emesis, angiogenesis and other disorders.

Abstract: The present invention relates to certain benzoamide piperidine containing compounds and related compounds that exhibit activity as NK-1 receptor antagonists, (e.g., substance P receptor antagonists), to pharmaceutical compositions containing them, and to their use in the treatment and prevention of central nervous system disorders, inflammatory disorders, cardiovascular disorders, ophthalmic disorders, gastrointestinal disorders, disorders caused by helicobacter pylori, disorders of the immune system, urinary incontinence, pain, migraine, emesis, angiogenesis and other disorders.

Abstract: Compounds of the formula ##STR1## wherein ring A, ring B, ring D, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6,R.sup.11, R.sup.12, R.sup.13, E, G, X and P are as defined below. The compounds of formula I are cholinesterase inhibitors and are useful in enhancing memory in patients suffering from dementia and Alzheimer's disease.

Abstract: Compounds of the formula ##STR1## wherein ring A, ring B, ring D, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.11, R.sup.12, R.sup.13, E, G, X and P are as defined below. The compounds of formula I are cholinesterase inhibitors and are useful in enhancing memory in patients suffering from dementia and Alzheimer's disease.

Abstract: A boring jig is provided having at least one drill bit guidance hole and having two clamps for holding the work. Provision is made for passing the drill bit through the guidance hole in one direction to drill a first work piece held under one clamp, then consecutively to pass the drill through the same guidance hole in the opposite direction to drill a mirror-image hole in a second work piece held under the other clamp.

Abstract: The present invention provides a new and distinct variety of hemp designated as ‘C2B’, wherein ‘C2B’ comprises a cannabidiol:cannabichromene:tetryhydrocannabinol ratio of 25:9:1 which is 4-8 times greater than the average amount of cannabichromene found in other Cannabis varieties.

Abstract: The present invention provides a new and distinct variety of hemp designated as ‘NaCl’, which has improved resilience to high salinity soil and drought conditions, as well as tolerance to small rootzone conditions.

Abstract: The present invention provides a new and distinct variety of hemp designated as ‘3 Crop’, wherein ‘3 Crop’ comprises improved resilience to high salinity soil.